Literature DB >> 17641647

Differentiation of skeletal muscle and integration of myotubes with silicon microstructures using serum-free medium and a synthetic silane substrate.

Mainak Das1, Kerry Wilson, Peter Molnar, James J Hickman.   

Abstract

This protocol describes a cell culture model to study the differentiation of fetal rat skeletal muscle cells. The model uses serum-free medium, a nonbiological substrate N-1[3(trimethoxysilyl)propyl] diethylenetriamine (DETA) and fabricated microcantilevers to promote the differentiation of dissociated rat myocytes into robust myotubes. In this protocol, we also describe how to characterize the myotubes on the basis of morphology, immunocytochemistry and electrophysiology. Here, four major techniques are employed: fabrication of cantilevers, surface modification of the glass and cantilever substrates with a DETA SAM, a serum-free medium and refined culture techniques. This culture system has potential applications in biocompatibility studies, bioartificial muscle engineering, skeletal muscle differentiation studies and for better understanding of myopathies and neuromuscular disorders. The model can be established in 26-33 d.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641647     DOI: 10.1038/nprot.2007.229

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  35 in total

1.  Enriching libraries of high-aspect-ratio micro- or nanostructures by rapid, low-cost, benchtop nanofabrication.

Authors:  Philseok Kim; Wilmer E Adorno-Martinez; Mughees Khan; Joanna Aizenberg
Journal:  Nat Protoc       Date:  2012-01-26       Impact factor: 13.491

Review 2.  Mechanical stretching for tissue engineering: two-dimensional and three-dimensional constructs.

Authors:  Brandon D Riehl; Jae-Hong Park; Il Keun Kwon; Jung Yul Lim
Journal:  Tissue Eng Part B Rev       Date:  2012-03-28       Impact factor: 6.389

3.  GATA-binding protein 4 (GATA-4) and T-cell acute leukemia 1 (TAL1) regulate myogenic differentiation and erythropoietin response via cross-talk with Sirtuin1 (Sirt1).

Authors:  Li Wang; Yi Jia; Heather Rogers; Yun-Ping Wu; Suming Huang; Constance Tom Noguchi
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

4.  Temporal neurotransmitter conditioning restores the functional activity of adult spinal cord neurons in long-term culture.

Authors:  Mainak Das; Neelima Bhargava; Abhijeet Bhalkikar; Jung Fong Kang; James J Hickman
Journal:  Exp Neurol       Date:  2007-09-26       Impact factor: 5.330

5.  Organismal Engineering: Towards a Robotic Taxonomic Key for Devices Using Organic Materials.

Authors:  Victoria A Webster-Wood; Ozan Akkus; Umut A Gurkan; Hillel J Chiel; Roger D Quinn
Journal:  Sci Robot       Date:  2017-11-22

6.  BTB-Kelch protein Krp1 regulates proliferation and differentiation of myoblasts.

Authors:  Camille W Paxton; Ruth A Cosgrove; Anja C Drozd; Emma L Wiggins; Sam Woodhouse; Rachel A Watson; Heather J Spence; Brad W Ozanne; Jennifer M Pell
Journal:  Am J Physiol Cell Physiol       Date:  2011-03-02       Impact factor: 4.249

7.  A defined long-term in vitro tissue engineered model of neuromuscular junctions.

Authors:  Mainak Das; John W Rumsey; Neelima Bhargava; Maria Stancescu; James J Hickman
Journal:  Biomaterials       Date:  2010-03-25       Impact factor: 12.479

Review 8.  Microfabricated mammalian organ systems and their integration into models of whole animals and humans.

Authors:  Jong H Sung; Mandy B Esch; Jean-Matthieu Prot; Christopher J Long; Alec Smith; James J Hickman; Michael L Shuler
Journal:  Lab Chip       Date:  2013-04-07       Impact factor: 6.799

9.  Fabrication of skeletal muscle constructs by topographic activation of cell alignment.

Authors:  Yi Zhao; Hansong Zeng; Jin Nam; Sudha Agarwal
Journal:  Biotechnol Bioeng       Date:  2009-02-01       Impact factor: 4.530

Review 10.  Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices.

Authors:  Shang Song; Shuvo Roy
Journal:  Biotechnol Bioeng       Date:  2016-01-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.